相关实验视频
Updated: Jun 30, 2025

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
440
阿里索尔B通过直接准VDAC1来调节AMPK/mTOR/SREBPs,以缓解超脂血症
概括
阿里索尔B (ALB) 通过通过VDAC1相互作用抑制脂质合成,有效治疗高脂血症. 这种天然化合物降低有害的胆固醇和甘油三,提供了一个有前途的治疗策略.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 超脂血症的发病与由固醇调节元素结合蛋白 (SREBPs) 调节的脂质合成有关.
- 阿利索尔B (ALB) 是阿利斯马的三类化合物,在代谢性疾病中具有潜力,但其对高脂血症的影响尚不清楚.
研究的目的:
- 为了研究Alisol B (ALB) 对高脂血症的治疗作用.
- 阐明ALB抑制SREBPs并降低脂质合成的机制.
主要方法:
- 实验室 (HepG2,HL7702细胞) 和体内 (C57BL/6J小鼠) 超脂血症模型被使用.
- 使用西斑,实时PCR,CETSA,分子动力学和超-LC/MS来分析ALB的影响和VDAC1相互作用.
- 评估了脂质特征,基因表达和蛋白质相互作用,以确定ALB的作用机制.
主要成果:
- 治疗ALB改善了脂质特征 (降低TC,TG,LDL-c;增加HDL-c) 和改善肝损伤.
- ALB通过调节AMPK/mTOR/SREBPs通路来抑制胆固醇和脂肪酸生物合成,独立于经典的上游激酶.
- 在特定的氨基酸位点,ALB直接与电压依赖性离子通道蛋白-1 (VDAC1) 结合,导致AMPK激活和随后的脂质合成抑制.
结论:
- VDAC1被确定为Alisol B (ALB) 的直接分子标.
- 通过与VDAC1相互作用,ALB抑制脂质合成,为高脂血症提供了一种新的治疗策略.
- 这项研究强调了VDAC1作为潜在的药物标,ALB作为超脂血症的候选治疗剂.
更多相关视频
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
18.9K
07:34Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
1.0K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
659
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
659
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Metabolism
9.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.4K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K